Search

everythinglearnresearchcommunity

for

Search:↓

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Natural products like flavonoids and phenolics may help treat or prevent COVID-19.

Natural plant compounds may offer safer COVID-19 treatments with fewer side effects.

HMPV causes respiratory infections, mainly managed with supportive care, and lacks a vaccine or specific treatment.

HIV medication ritonavir can increase the effects of nasal sprays like fluticasone, causing Cushing's syndrome.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Human placenta hydrolysate may help treat COVID-19 by reducing virus replication and boosting immune response.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

A prostate cancer drug can lower the levels of a protein that the coronavirus uses to enter lung cells.

Cepharanthine shows promise as a COVID-19 treatment.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Balancing testosterone may reduce COVID-19 severity.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Plant compounds may boost antiviral treatments.

A new method using human lung cells helps find drugs to block and reduce inflammation from SARS-CoV-2.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

Hair loss can happen after severe H1N1 flu but usually grows back in 4 months.

The COVID-19 vaccine is viewed more negatively and causes more side effects than the flu vaccine in Korean patients with lupus.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.